PortfoliosLab logoPortfoliosLab logo
FTXH vs. RBIL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. RBIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, FTXH achieves a 8.95% return, which is significantly higher than RBIL's 2.31% return.


FTXH

1D
1.27%
1M
2.75%
YTD
8.95%
6M
7.56%
1Y
42.53%
3Y*
12.47%
5Y*
8.39%
10Y*

RBIL

1D
-0.05%
1M
-0.20%
YTD
2.31%
6M
2.35%
1Y
3.95%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FTXH vs. RBIL - Yearly Performance Comparison


Correlation

The correlation between FTXH and RBIL is -0.20, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

-0.20

Correlation (All Time)
Calculated using the full available price history since Feb 25, 2025

-0.16

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. RBIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FTXH
FTXH Risk / Return Rank: 8383
Overall Rank
FTXH Sharpe Ratio Rank: 8181
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 8686
Sortino Ratio Rank
FTXH Omega Ratio Rank: 7474
Omega Ratio Rank
FTXH Calmar Ratio Rank: 9191
Calmar Ratio Rank
FTXH Martin Ratio Rank: 8484
Martin Ratio Rank

RBIL
RBIL Risk / Return Rank: 9797
Overall Rank
RBIL Sharpe Ratio Rank: 9797
Sharpe Ratio Rank
RBIL Sortino Ratio Rank: 9797
Sortino Ratio Rank
RBIL Omega Ratio Rank: 9898
Omega Ratio Rank
RBIL Calmar Ratio Rank: 9595
Calmar Ratio Rank
RBIL Martin Ratio Rank: 9797
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FTXH vs. RBIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTXHRBILDifference
Sharpe ratioReturn per unit of total volatility

-1.69

Sortino ratioReturn per unit of downside risk

-2.72

Omega ratioGain probability vs. loss probability

1.42

2.06

-0.64

Calmar ratioReturn relative to maximum drawdown

5.72

7.59

-1.86

Martin ratioReturn relative to average drawdown

16.84

44.07

-27.24

FTXH vs. RBIL - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.49, which is lower than the RBIL Sharpe Ratio of 4.18. The chart below compares the historical Sharpe Ratios of FTXH and RBIL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FTXH vs. RBIL - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, which is greater than RBIL's maximum drawdown of -0.52%. Use the drawdown chart below to compare losses from any high point for FTXH and RBIL.


Loading charts...

Drawdown Indicators


FTXHRBILDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-0.52%

-31.59%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

-0.52%

-6.95%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

Current Drawdown

Current decline from peak

-0.74%

-0.51%

-0.23%

Average Drawdown

Average peak-to-trough decline

-5.81%

-0.07%

-5.74%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.53%

0.09%

+2.44%

Volatility

FTXH vs. RBIL - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 5.36% compared to F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF (RBIL) at 0.36%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than RBIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTXHRBILDifference

Volatility (1M)

Calculated over the trailing 1-month period

5.36%

0.36%

+5.00%

Volatility (6M)

Calculated over the trailing 6-month period

11.98%

0.85%

+11.13%

Volatility (1Y)

Calculated over the trailing 1-year period

17.17%

0.95%

+16.22%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.37%

1.07%

+15.30%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.41%

1.07%

+17.34%

FTXH vs. RBIL - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than RBIL's 0.17% expense ratio.


Dividends

FTXH vs. RBIL - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.18%, less than RBIL's 4.38% yield.


PositionTTM2025202420232022202120202019201820172016
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.18%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%
RBIL
F/m Ultrashort Treasury Inflation-Protected Security (TIPS) ETF
4.38%3.65%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


FTXH and RBIL have a correlation of -0.20, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FTXH has higher volatility (5.36%) compared to RBIL (0.36%). In terms of maximum drawdown, FTXH dropped -32.11% vs RBIL's -0.52%.

On 1-year performance, FTXH leads with 42.53% vs 3.95% for RBIL. On fees, RBIL is cheaper at 0.17% per year. On volatility, RBIL has been the lower-risk option at 0.36%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, FTXH has performed better with a 42.53% return vs 3.95%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RBIL is cheaper with a 0.17% expense ratio, compared with 0.60% for FTXH.

RBIL has the higher dividend yield at 4.38%, compared with 1.18% for FTXH.

FTXH is categorized as Health & Biotech Equities, while RBIL is Inflation-Protected Bonds. FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while RBIL tracks Bloomberg US Ultrashort TIPS 1-13 Months Index. They also come from different issuers: First Trust and F/m. Their fees differ too: 0.60% for FTXH and 0.17% for RBIL.

RBIL currently has the higher Sharpe Ratio (4.18 vs 2.49), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTXH and RBIL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer